VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desir...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US |
| description | The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE69228813TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE69228813TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE69228813TT23</originalsourceid><addsrcrecordid>eNqNjLEKwjAURbs4iPoPxUnBDE1FdKztqwkkL5K8qu0iInESLdRPcPWr_DEz6O5yLxfOuf3otQO7Bywq3MQ7gzFnE85QkjVszsjKUlXGaiBRqzVgY2o1ZcksZXmdKyPgkGEhg9ZUNl6DCEv9nqi2xkl8P7WE2Jl9yK3IrM4aqEi6XECwXKY1oANqggY4jHqX07Xzo28PonEJlAvm2_vRd-3p7G_-cSxgseJ8uUxSIp7-BX0A6ltCQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><source>esp@cenet</source><creator>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE ; ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB ; LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE ; LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB ; MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US ; PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</creator><creatorcontrib>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE ; ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB ; LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE ; LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB ; MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US ; PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</creatorcontrib><description>The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.</description><edition>6</edition><language>ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990805&DB=EPODOC&CC=DE&NR=69228813T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990805&DB=EPODOC&CC=DE&NR=69228813T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE</creatorcontrib><creatorcontrib>ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB</creatorcontrib><creatorcontrib>LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE</creatorcontrib><creatorcontrib>LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB</creatorcontrib><creatorcontrib>MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US</creatorcontrib><creatorcontrib>PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</creatorcontrib><title>VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><description>The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAURbs4iPoPxUnBDE1FdKztqwkkL5K8qu0iInESLdRPcPWr_DEz6O5yLxfOuf3otQO7Bywq3MQ7gzFnE85QkjVszsjKUlXGaiBRqzVgY2o1ZcksZXmdKyPgkGEhg9ZUNl6DCEv9nqi2xkl8P7WE2Jl9yK3IrM4aqEi6XECwXKY1oANqggY4jHqX07Xzo28PonEJlAvm2_vRd-3p7G_-cSxgseJ8uUxSIp7-BX0A6ltCQw</recordid><startdate>19990805</startdate><enddate>19990805</enddate><creator>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE</creator><creator>ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB</creator><creator>LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE</creator><creator>LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB</creator><creator>MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US</creator><creator>PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</creator><scope>EVB</scope></search><sort><creationdate>19990805</creationdate><title>VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><author>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE ; ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB ; LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE ; LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB ; MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US ; PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE69228813TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1999</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE</creatorcontrib><creatorcontrib>ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB</creatorcontrib><creatorcontrib>LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE</creatorcontrib><creatorcontrib>LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB</creatorcontrib><creatorcontrib>MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US</creatorcontrib><creatorcontrib>PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE</au><au>ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB</au><au>LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE</au><au>LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB</au><au>MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US</au><au>PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><date>1999-08-05</date><risdate>1999</risdate><abstract>The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DE69228813TT2 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARKSTEDT,%20MAJ%20ELISABETH%20HOLME,%20S-427%2000%20BILLDAL,%20SE&rft.date=1999-08-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE69228813TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |